triamcinolon léČiva 1mg/g mast
zentiva, k.s., praha array - 1482 triamcinolon-acetonid - mast - 1mg/g - triamcinolon
bilamcar 16mg/10mg tvrdá tobolka
swyssi ag, frankfurt am main array - 15205 kandesartan-cilexetil; 12990 amlodipin-besilÁt - tvrdá tobolka - 16mg/10mg - kandesartan a amlodipin
bilamcar 16mg/5mg tvrdá tobolka
swyssi ag, frankfurt am main array - 15205 kandesartan-cilexetil; 12990 amlodipin-besilÁt - tvrdá tobolka - 16mg/5mg - kandesartan a amlodipin
bilamcar 8mg/10mg tvrdá tobolka
swyssi ag, frankfurt am main array - 15205 kandesartan-cilexetil; 12990 amlodipin-besilÁt - tvrdá tobolka - 8mg/10mg - kandesartan a amlodipin
bilamcar 8mg/5mg tvrdá tobolka
swyssi ag, frankfurt am main array - 15205 kandesartan-cilexetil; 12990 amlodipin-besilÁt - tvrdá tobolka - 8mg/5mg - kandesartan a amlodipin
otibiovin ušní kapky, roztok
bioveta, a.s. - triamcinolon a antiinfectives - ušní kapky, roztok - kortikosteroidy a antiinfectives v kombinaci - psi, kočky
otopet therapy ušní kapky, suspenze
fatro, s.p.a. - triamcinolon a antiinfectives - ušní kapky, suspenze - kortikosteroidy a antiinfectives v kombinaci - kočky, psi
otomax ušní kapky, suspenze
intervet international, b.v. - triamcinolon a antiinfectives - ušní kapky, suspenze - kortikosteroidy a antiinfectives v kombinaci - psi
spikevax (previously covid-19 vaccine moderna)
moderna biotech spain, s.l. - single-stranded, 5’-capped messenger rna (mrna) produced using a cell-free in vitro transcription from the corresponding dna templates, encoding the viral spike (s) protein of sars-cov-2 - covid-19 virus infection - vakcíny - spikevax is indicated for active immunisation to prevent covid-19 caused by sars-cov-2 in individuals 6 months of age and older. spikevax bivalent original/omicron ba. 1 is indicated for active immunisation to prevent covid-19 caused by sars-cov-2 in individuals 6 years of age and older who have previously received at least a primary vaccination course against covid-19. spikevax bivalent original/omicron ba. 4-5 is indicated for active immunisation to prevent covid-19 caused by sars-cov-2 in individuals 6 months of age and older. spikevax xbb. 5 is indicated for active immunisation to prevent covid 19 caused by sars-cov-2 in individuals 6 months of age and older. the use of this vaccine should be in accordance with official recommendations.